Filing Details

Accession Number:
0001144204-10-055794
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-27 16:01:13
Reporting Period:
2010-10-27
Filing Date:
2010-10-27
Accepted Time:
2010-10-27 16:01:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1059784 Generex Biotechnology Corp GNBT Pharmaceutical Preparations (2834) 820490211
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1125858 C Rose Perri 33 Harbour Square, Suite 202
Toronto A6 M5J 2G2
Coo, Cfo& Treas. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-27 54,000 $0.35 458,726 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,451,246 Indirect By Estate of Mark Perri
Common Stock 341,496 Indirect By EBI, Inc.
Common Stock 953,667 Indirect By GHI, Inc.
Common Stock 953,667 Indirect By GHI, Inc.
Footnotes
  1. This aggregate number of shares does not include 200,000 shares of common stock underlying stock options which survived the death of Mark Perri, who was the reporting person's brother.
  2. The reporting person may be deemed to beneficially own such 341,496 shares owed of record by EBI, Inc. because the reporting person holds the right to vote such shares.
  3. The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares.
  4. The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. because the reporting person holds the right to vote such shares.